United States Healthcare Equipment & Supplies

Beta Bionics, Inc. (BBNX)

Track

Track

Beta Bionics experienced twenty-six insider trading transactions over the past ninety days, totaling approximately 5.8 million dollars in sales. Executives, including the CEO and commercial officers, executed these divestments following a 31.9 percent stock price increase. The activity occurred after the most recent earnings report, which showed a 14.5 percent earnings per share beat.
Ticker: BBNX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Beta Bionics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Jones Christy Non-Executive Director
Transaction date
Planned sale
Price
211.51
Quantity 41,682 -39.7%
Value US$445,573
CHRISTINA JONES Director Non-Executive Director
Transaction date
Proposed sale
Price
476.97
Quantity 61,808
Value US$3,261,388
2.3
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
136.55
Quantity 31,591 +4.5%
Value US$3,578,714
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Planned sale
Price
22.00
Quantity 1,000 -1.5%
Value US$100,000
2.3
MICHAEL MENSINGER Officer Officer
Transaction date
Proposed sale
Price
19.23
Quantity 1,000
Value US$100,000
2.3
MARK HOPMAN Officer Officer
Transaction date
Proposed sale
Price
19.23
Quantity 1,000
Value US$100,000
2.3
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
15.52
Quantity 1,000 -0.9%
Value US$100,000
2.3
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
18.46
Quantity 1,000 -29.7%
Value US$100,000
2.3
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
18.46
Quantity 1,000 -29.7%
Value US$100,000
2.3
MARK HOPMAN Officer Officer
Transaction date
Proposed sale
Price
19.33
Quantity 1,000
Value US$100,000
2.3
Saint Sean President & CEO Executive Director
Transaction date
Planned sale
Price
20.08
Quantity 5,641 -1.4%
Value US$113,259
2.3
Sean Saint Officer Officer
Transaction date
Proposed sale
Price
20.08
Quantity 5,641
Value US$113,259
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Sale
Price
19.11
Quantity 4,375 -2.4%
Value US$83,620
2.3
Feider Stephen Chief Financial Officer Officer
Transaction date
Sale
Price
19.11
Quantity 6,675 -4.0%
Value US$127,580
2.3
Hopman Mark Chief Commercial Officer Officer
Transaction date
Sale
Price
19.11
Quantity 5,327 -4.1%
Value US$101,815
2.3
Saint Sean President & CEO Executive Director
Transaction date
Sale
Price
19.11
Quantity 16,867 -4.0%
Value US$322,381
2.3
Russell Steven Jon Chief Medical Officer Officer
Transaction date
Sale
Price
19.11
Quantity 4,221 -2.4%
Value US$80,676
2.3
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
19.42
Quantity 6,675
Value US$129,595
2.3
Steven Jon Russell Officer Officer
Transaction date
Proposed sale
Price
19.42
Quantity 4,221
Value US$81,951
2.3
Mark Hopman Officer Officer
Transaction date
Proposed sale
Price
19.42
Quantity 5,327
Value US$103,424
2.3
Sean Saint Officer; Director Executive Director
Transaction date
Proposed sale
Price
19.42
Quantity 16,867
Value US$327,473
2.3
Michael R. Mensinger Officer Officer
Transaction date
Proposed sale
Price
19.42
Quantity 4,375
Value US$84,941
2.3
Feider Stephen Chief Financial Officer Officer
Transaction date
Planned sale
Price
17.03
Quantity 4,896 -2.9%
Value US$83,381
2.3
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
17.03
Quantity 4,896
Value US$83,381
2.3
Feider Stephen Chief Financial Officer Officer
Transaction date
Planned sale
Price
17.05
Quantity 5,104 -3.0%
Value US$87,006
2.3
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
17.05
Quantity 5,104
Value US$87,007
2.3
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
15.01
Quantity 1,258 -1.0%
Value US$18,880
Jones Christy Non-Executive Director
Transaction date
Planned sale
Price
15.00
Quantity 1,406 -5.1%
Value US$21,090
2.3
Mark Hopman Officer Officer
Transaction date
Proposed sale
Price
14.97
Quantity 1,258
Value US$18,827
CHRISTINA JONES Director Non-Executive Director
Transaction date
Proposed sale
Price
13.67
Quantity 1,406
Value US$19,220
Jones Christy Non-Executive Director
Transaction date
Planned sale
Price
14.00
Quantity 2,811 -9.3%
Value US$39,354
2.3
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
12.31
Quantity 275 -0.2%
Value US$3,385
CHRISTINA JONES Director Non-Executive Director
Transaction date
Proposed sale
Price
12.45
Quantity 2,811
Value US$34,997
2.3
Mark Hopman Officer Officer
Transaction date
Proposed sale
Price
12.31
Quantity 275
Value US$3,385
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Sale
Price
12.61
Quantity 4,378 -2.3%
Value US$55,194
2.3
Russell Steven Jon Chief Medical Officer Officer
Transaction date
Sale
Price
12.61
Quantity 4,222 -2.4%
Value US$53,227
2.3
Saint Sean President & CEO Executive Director
Transaction date
Sale
Price
12.61
Quantity 16,872 -3.9%
Value US$212,707
2.3
Feider Stephen Chief Financial Officer Officer
Transaction date
Sale
Price
12.61
Quantity 6,676 -3.9%
Value US$84,165
2.3
Hopman Mark Chief Commercial Officer Officer
Transaction date
Sale
Price
12.61
Quantity 5,329 -3.9%
Value US$67,183
2.3
Michael R. Mensinger Officer Officer
Transaction date
Proposed sale
Price
12.79
Quantity 4,378
Value US$55,995
2.3
Steven Jon Russell Officer Officer
Transaction date
Proposed sale
Price
12.79
Quantity 4,222
Value US$53,999
2.3
Mark Hopman Officer Officer
Transaction date
Proposed sale
Price
12.79
Quantity 5,329
Value US$68,158
2.3
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
12.79
Quantity 6,676
Value US$85,386
2.3
Sean Saint Officer; Director Executive Director
Transaction date
Proposed sale
Price
12.79
Quantity 16,872
Value US$215,793
Lezack Adam Non-Executive Director
Transaction date
Planned sale
Price
11.21
Quantity 998 -3.5%
Value US$11,188
Jones Christy Non-Executive Director
Transaction date
Planned sale
Price
9.95
Quantity 1,998 -13.1%
Value US$19,880
Lezack Adam Non-Executive Director
Transaction date
Planned sale
Price
9.95
Quantity 1,000 -8.0%
Value US$9,950
CHRISTINA JONES Director Non-Executive Director
Transaction date
Proposed sale
Price
10.11
Quantity 1,998
Value US$20,200
ADAM LEZACK Director Non-Executive Director
Transaction date
Proposed sale
Price
10.11
Quantity 1,998
Value US$20,200
2.3
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
11.57
Quantity 353 -0.3%
Value US$4,084
2.3
Mark Hopman Officer Officer
Transaction date
Proposed sale
Price
11.57
Quantity 353
Value US$4,084
2.3
Michael R. Mensinger Officer Officer
Transaction date
Proposed sale
Price
12.52
Quantity 1,064
Value US$13,321
2.3
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
12.52
Quantity 1,428
Value US$17,879
2.3
Sean Saint Officer; Director Executive Director
Transaction date
Proposed sale
Price
12.52
Quantity 3,384
Value US$42,368
2.3
Saint Sean President & CEO Executive Director
Transaction date
Sale
Price
12.36
Quantity 3,384 -0.8%
Value US$41,832
2.3
Feider Stephen Chief Financial Officer Officer
Transaction date
Sale
Price
12.36
Quantity 1,428 -0.8%
Value US$17,652
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Sale
Price
12.36
Quantity 1,064 -0.6%
Value US$13,153
2.3
Hopman Mark Chief Commercial Officer Officer
Transaction date
Sale
Price
12.36
Quantity 834 -0.6%
Value US$10,310
2.3
Russell Steven Jon Chief Medical Officer Officer
Transaction date
Sale
Price
12.36
Quantity 1,026 -0.6%
Value US$12,683
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Planned sale
Price
30.10
Quantity 2,200 -2.7%
Value US$66,221
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Planned sale
Price
30.20
Quantity 600 -0.7%
Value US$18,118
2.3
Mensinger Mike Chief Product Officer Officer
Transaction date
Planned sale
Price
29.56
Quantity 7,200 -7.9%
Value US$212,832
2.3
Feider Stephen Chief Financial Officer Officer
Transaction date
Planned sale
Price
29.53
Quantity 20,000 -31.9%
Value US$590,680
2.3
MICHAEL MENSINGER Officer Officer
Transaction date
Proposed sale
Price
30.47
Quantity 10,000
Value US$304,700
2.3
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
29.53
Quantity 20,000
Value US$590,680
2.3
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
29.53
Quantity 20,000
Value US$590,680
2.3
Hopman Mark Chief Commercial Officer Officer
Transaction date
Planned sale
Price
30.66
Quantity 2,061 -1.5%
Value US$63,192
2.3
Mark Hopman Officer Officer
Transaction date
Proposed sale
Price
30.66
Quantity 2,061
Value US$63,192
2.3
Hopman Mark Chief Commercial Officer Officer
Transaction date
Sale
Price
29.34
Quantity 856 -0.6%
Value US$25,112
2.3
Russell Steven Jon Chief Medical Officer Officer
Transaction date
Sale
Price
29.34
Quantity 1,025 -0.6%
Value US$30,069
2.3
Sean Saint Officer; Director Executive Director
Transaction date
Proposed sale
Price
29.34
Quantity 3,278
Value US$96,163
2.3
Stephen Feider Officer Officer
Transaction date
Proposed sale
Price
29.34
Quantity 1,427
Value US$41,862
2.3
Michael R. Mensinger Officer Officer
Transaction date
Proposed sale
Price
29.34
Quantity 1,063
Value US$31,184
2.3
Saint Sean President & CEO Executive Director
Transaction date
Sale
Price
29.34
Quantity 3,278 -3.2%
Value US$96,163
2.3
Feider Stephen Chief Financial Officer Officer
Transaction date
Sale
Price
29.34
Quantity 1,427 -3.2%
Value US$41,862
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-23 2026-09-22 PlS Planned sale
Jones Christy
Non-Executive Director
41,682 -39.7%
211.51
US$445,573 		41,682 -39.7% 211.51 US$445,573
2026-09-22 2026-09-22 PrS Proposed sale
CHRISTINA JONES

Director

Non-Executive Director
61,808
476.97
US$3,261,388 		61,808 476.97 US$3,261,388
2026-09-17 2026-09-16 PlS Planned sale
2.3
Hopman Mark

Chief Commercial Officer

Officer
31,591 +4.5%
136.55
US$3,578,714 		31,591 +4.5% 136.55 US$3,578,714
2026-09-17 2026-09-16 PlS Planned sale
2.3
Mensinger Mike

Chief Product Officer

Officer
1,000 -1.5%
22.00
US$100,000 		1,000 -1.5% 22.00 US$100,000
2026-09-16 2026-09-16 PrS Proposed sale
2.3
MICHAEL MENSINGER

Officer

Officer
1,000
19.23
US$100,000 		1,000 19.23 US$100,000
2026-09-16 2026-09-16 PrS Proposed sale
2.3
MARK HOPMAN

Officer

Officer
1,000
19.23
US$100,000 		1,000 19.23 US$100,000
2026-09-15 2026-09-14 PlS Planned sale
2.3
Hopman Mark

Chief Commercial Officer

Officer
1,000 -0.9%
15.52
US$100,000 		1,000 -0.9% 15.52 US$100,000
2026-09-10 2026-09-09 PlS Planned sale
2.3
Hopman Mark

Chief Commercial Officer

Officer
1,000 -29.7%
18.46
US$100,000 		1,000 -29.7% 18.46 US$100,000
2026-09-10 2026-09-09 PlS Planned sale
2.3
Hopman Mark

Chief Commercial Officer

Officer
1,000 -29.7%
18.46
US$100,000 		1,000 -29.7% 18.46 US$100,000
2026-09-09 2026-09-09 PrS Proposed sale
2.3
MARK HOPMAN

Officer

Officer
1,000
19.33
US$100,000 		1,000 19.33 US$100,000
2026-09-04 2026-09-03 PlS Planned sale
2.3
Saint Sean

President & CEO

Executive Director
5,641 -1.4%
20.08
US$113,259 		5,641 -1.4% 20.08 US$113,259
2026-09-03 2026-09-03 PrS Proposed sale
2.3
Sean Saint

Officer

Officer
5,641
20.08
US$113,259 		5,641 20.08 US$113,259
2026-09-03 2026-09-02 S Sale
2.3
Mensinger Mike

Chief Product Officer

Officer
4,375 -2.4%
19.11
US$83,620 		4,375 -2.4% 19.11 US$83,620
2026-09-03 2026-09-02 S Sale
2.3
Feider Stephen

Chief Financial Officer

Officer
6,675 -4.0%
19.11
US$127,580 		6,675 -4.0% 19.11 US$127,580
2026-09-03 2026-09-02 S Sale
2.3
Hopman Mark

Chief Commercial Officer

Officer
5,327 -4.1%
19.11
US$101,815 		5,327 -4.1% 19.11 US$101,815
2026-09-03 2026-09-02 S Sale
2.3
Saint Sean

President & CEO

Executive Director
16,867 -4.0%
19.11
US$322,381 		16,867 -4.0% 19.11 US$322,381
2026-09-03 2026-09-02 S Sale
2.3
Russell Steven Jon

Chief Medical Officer

Officer
4,221 -2.4%
19.11
US$80,676 		4,221 -2.4% 19.11 US$80,676
2026-09-03 2026-09-02 PrS Proposed sale
2.3
Stephen Feider

Officer

Officer
6,675
19.42
US$129,595 		6,675 19.42 US$129,595
2026-09-03 2026-09-02 PrS Proposed sale
2.3
Steven Jon Russell

Officer

Officer
4,221
19.42
US$81,951 		4,221 19.42 US$81,951
2026-09-03 2026-09-02 PrS Proposed sale
2.3
Mark Hopman

Officer

Officer
5,327
19.42
US$103,424 		5,327 19.42 US$103,424
2026-09-03 2026-09-02 PrS Proposed sale
2.3
Sean Saint

Officer; Director

Executive Director
16,867
19.42
US$327,473 		16,867 19.42 US$327,473
2026-09-03 2026-09-02 PrS Proposed sale
2.3
Michael R. Mensinger

Officer

Officer
4,375
19.42
US$84,941 		4,375 19.42 US$84,941
2026-06-30 2026-06-29 PlS Planned sale
2.3
Feider Stephen

Chief Financial Officer

Officer
4,896 -2.9%
17.03
US$83,381 		4,896 -2.9% 17.03 US$83,381
2026-06-29 2026-06-29 PrS Proposed sale
2.3
Stephen Feider

Officer

Officer
4,896
17.03
US$83,381 		4,896 17.03 US$83,381
2026-06-30 2026-06-26 PlS Planned sale
2.3
Feider Stephen

Chief Financial Officer

Officer
5,104 -3.0%
17.05
US$87,006 		5,104 -3.0% 17.05 US$87,006
2026-06-26 2026-06-26 PrS Proposed sale
2.3
Stephen Feider

Officer

Officer
5,104
17.05
US$87,007 		5,104 17.05 US$87,007
2026-06-25 2026-06-24 PlS Planned sale
2.3
Hopman Mark

Chief Commercial Officer

Officer
1,258 -1.0%
15.01
US$18,880 		1,258 -1.0% 15.01 US$18,880
2026-06-25 2026-06-24 PlS Planned sale
Jones Christy
Non-Executive Director
1,406 -5.1%
15.00
US$21,090 		1,406 -5.1% 15.00 US$21,090
2026-06-24 2026-06-24 PrS Proposed sale
2.3
Mark Hopman

Officer

Officer
1,258
14.97
US$18,827 		1,258 14.97 US$18,827
2026-06-24 2026-06-24 PrS Proposed sale
CHRISTINA JONES

Director

Non-Executive Director
1,406
13.67
US$19,220 		1,406 13.67 US$19,220
2026-06-05 2026-06-04 PlS Planned sale
Jones Christy
Non-Executive Director
2,811 -9.3%
14.00
US$39,354 		2,811 -9.3% 14.00 US$39,354
2026-06-05 2026-06-04 PlS Planned sale
2.3
Hopman Mark

Chief Commercial Officer

Officer
275 -0.2%
12.31
US$3,385 		275 -0.2% 12.31 US$3,385
2026-06-04 2026-06-04 PrS Proposed sale
CHRISTINA JONES

Director

Non-Executive Director
2,811
12.45
US$34,997 		2,811 12.45 US$34,997
2026-06-04 2026-06-04 PrS Proposed sale
2.3
Mark Hopman

Officer

Officer
275
12.31
US$3,385 		275 12.31 US$3,385
2026-06-03 2026-06-02 S Sale
2.3
Mensinger Mike

Chief Product Officer

Officer
4,378 -2.3%
12.61
US$55,194 		4,378 -2.3% 12.61 US$55,194
2026-06-03 2026-06-02 S Sale
2.3
Russell Steven Jon

Chief Medical Officer

Officer
4,222 -2.4%
12.61
US$53,227 		4,222 -2.4% 12.61 US$53,227
2026-06-03 2026-06-02 S Sale
2.3
Saint Sean

President & CEO

Executive Director
16,872 -3.9%
12.61
US$212,707 		16,872 -3.9% 12.61 US$212,707
2026-06-03 2026-06-02 S Sale
2.3
Feider Stephen

Chief Financial Officer

Officer
6,676 -3.9%
12.61
US$84,165 		6,676 -3.9% 12.61 US$84,165
2026-06-03 2026-06-02 S Sale
2.3
Hopman Mark

Chief Commercial Officer

Officer
5,329 -3.9%
12.61
US$67,183 		5,329 -3.9% 12.61 US$67,183
2026-06-03 2026-06-02 PrS Proposed sale
2.3
Michael R. Mensinger

Officer

Officer
4,378
12.79
US$55,995 		4,378 12.79 US$55,995
2026-06-03 2026-06-02 PrS Proposed sale
2.3
Steven Jon Russell

Officer

Officer
4,222
12.79
US$53,999 		4,222 12.79 US$53,999
2026-06-03 2026-06-02 PrS Proposed sale
2.3
Mark Hopman

Officer

Officer
5,329
12.79
US$68,158 		5,329 12.79 US$68,158
2026-06-03 2026-06-02 PrS Proposed sale
2.3
Stephen Feider

Officer

Officer
6,676
12.79
US$85,386 		6,676 12.79 US$85,386
2026-06-03 2026-06-02 PrS Proposed sale
2.3
Sean Saint

Officer; Director

Executive Director
16,872
12.79
US$215,793 		16,872 12.79 US$215,793
2026-05-26 2026-05-22 PlS Planned sale
Lezack Adam
Non-Executive Director
998 -3.5%
11.21
US$11,188 		998 -3.5% 11.21 US$11,188
2026-05-26 2026-05-21 PlS Planned sale
Jones Christy
Non-Executive Director
1,998 -13.1%
9.95
US$19,880 		1,998 -13.1% 9.95 US$19,880
2026-05-26 2026-05-21 PlS Planned sale
Lezack Adam
Non-Executive Director
1,000 -8.0%
9.95
US$9,950 		1,000 -8.0% 9.95 US$9,950
2026-05-21 2026-05-21 PrS Proposed sale
CHRISTINA JONES

Director

Non-Executive Director
1,998
10.11
US$20,200 		1,998 10.11 US$20,200
2026-05-21 2026-05-21 PrS Proposed sale
ADAM LEZACK

Director

Non-Executive Director
1,998
10.11
US$20,200 		1,998 10.11 US$20,200
2026-03-05 2026-03-04 PlS Planned sale
2.3
Hopman Mark

Chief Commercial Officer

Officer
353 -0.3%
11.57
US$4,084 		353 -0.3% 11.57 US$4,084
2026-03-04 2026-03-04 PrS Proposed sale
2.3
Mark Hopman

Officer

Officer
353
11.57
US$4,084 		353 11.57 US$4,084
2026-03-04 2026-03-02 PrS Proposed sale
2.3
Michael R. Mensinger

Officer

Officer
1,064
12.52
US$13,321 		1,064 12.52 US$13,321
2026-03-04 2026-03-02 PrS Proposed sale
2.3
Stephen Feider

Officer

Officer
1,428
12.52
US$17,879 		1,428 12.52 US$17,879
2026-03-04 2026-03-02 PrS Proposed sale
2.3
Sean Saint

Officer; Director

Executive Director
3,384
12.52
US$42,368 		3,384 12.52 US$42,368
2026-03-03 2026-03-02 S Sale
2.3
Saint Sean

President & CEO

Executive Director
3,384 -0.8%
12.36
US$41,832 		3,384 -0.8% 12.36 US$41,832
2026-03-03 2026-03-02 S Sale
2.3
Feider Stephen

Chief Financial Officer

Officer
1,428 -0.8%
12.36
US$17,652 		1,428 -0.8% 12.36 US$17,652
2026-03-03 2026-03-02 S Sale
2.3
Mensinger Mike

Chief Product Officer

Officer
1,064 -0.6%
12.36
US$13,153 		1,064 -0.6% 12.36 US$13,153
2026-03-03 2026-03-02 S Sale
2.3
Hopman Mark

Chief Commercial Officer

Officer
834 -0.6%
12.36
US$10,310 		834 -0.6% 12.36 US$10,310
2026-03-03 2026-03-02 S Sale
2.3
Russell Steven Jon

Chief Medical Officer

Officer
1,026 -0.6%
12.36
US$12,683 		1,026 -0.6% 12.36 US$12,683
2026-01-07 2026-01-06 PlS Planned sale
2.3
Mensinger Mike

Chief Product Officer

Officer
2,200 -2.7%
30.10
US$66,221 		2,200 -2.7% 30.10 US$66,221
2026-01-05 2026-01-02 PlS Planned sale
2.3
Mensinger Mike

Chief Product Officer

Officer
600 -0.7%
30.20
US$18,118 		600 -0.7% 30.20 US$18,118
2026-01-05 2026-01-02 PlS Planned sale
2.3
Mensinger Mike

Chief Product Officer

Officer
7,200 -7.9%
29.56
US$212,832 		7,200 -7.9% 29.56 US$212,832
2026-01-05 2026-01-02 PlS Planned sale
2.3
Feider Stephen

Chief Financial Officer

Officer
20,000 -31.9%
29.53
US$590,680 		20,000 -31.9% 29.53 US$590,680
2026-01-02 2026-01-02 PrS Proposed sale
2.3
MICHAEL MENSINGER

Officer

Officer
10,000
30.47
US$304,700 		10,000 30.47 US$304,700
2026-01-02 2026-01-02 PrS Proposed sale
2.3
Stephen Feider

Officer

Officer
20,000
29.53
US$590,680 		20,000 29.53 US$590,680
2026-01-02 2026-01-02 PrS Proposed sale
2.3
Stephen Feider

Officer

Officer
20,000
29.53
US$590,680 		20,000 29.53 US$590,680
2026-03-16 2025-12-04 PlS Planned sale
2.3
Hopman Mark

Chief Commercial Officer

Officer
2,061 -1.5%
30.66
US$63,192 		2,061 -1.5% 30.66 US$63,192
2025-12-04 2025-12-04 PrS Proposed sale
2.3
Mark Hopman

Officer

Officer
2,061
30.66
US$63,192 		2,061 30.66 US$63,192
2026-03-16 2025-12-02 S Sale
2.3
Hopman Mark

Chief Commercial Officer

Officer
856 -0.6%
29.34
US$25,112 		856 -0.6% 29.34 US$25,112
2026-03-16 2025-12-02 S Sale
2.3
Russell Steven Jon

Chief Medical Officer

Officer
1,025 -0.6%
29.34
US$30,069 		1,025 -0.6% 29.34 US$30,069
2025-12-04 2025-12-02 PrS Proposed sale
2.3
Sean Saint

Officer; Director

Executive Director
3,278
29.34
US$96,163 		3,278 29.34 US$96,163
2025-12-04 2025-12-02 PrS Proposed sale
2.3
Stephen Feider

Officer

Officer
1,427
29.34
US$41,862 		1,427 29.34 US$41,862
2025-12-04 2025-12-02 PrS Proposed sale
2.3
Michael R. Mensinger

Officer

Officer
1,063
29.34
US$31,184 		1,063 29.34 US$31,184
2025-12-04 2025-12-02 S Sale
2.3
Saint Sean

President & CEO

Executive Director
3,278 -3.2%
29.34
US$96,163 		3,278 -3.2% 29.34 US$96,163
2025-12-04 2025-12-02 S Sale
2.3
Feider Stephen

Chief Financial Officer

Officer
1,427 -3.2%
29.34
US$41,862 		1,427 -3.2% 29.34 US$41,862
Explore more

More insider trading research around Beta Bionics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America